Biological treatment of patient with ulcerative colitis during pregnancy;Biologická léčba nemocné s ulceró zníkolitidou v průběhu gravidity

Ceska a Slovenska Gastroenterologie a Hepatologie

Volumn 65, Issue 2, 2011, Pages 75-77

  Koželuhová, Jana ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Infliximab; Pregnancy; Ulcerative colitis

Indexed keywords

INFLIXIMAB;

ARTICLE; CASE REPORT; ECTOPIC PREGNANCY; FEMALE; HUMAN; LAPAROSCOPIC SURGERY; PREGNANCY; SALPINGECTOMY; ULCERATIVE COLITIS; BIOLOGICAL THERAPY; REMISSION;

EID: 83455187147     PISSN: 1213323X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. van der Woude JC, Kolacek S, Dotan I et al. European evidenced-based consensus on reproduction in inflammatory bowel disease. J Crohns Colitis 2010; 4(5): 493-510.
2. Lukáš M, Ďuricová D, Bortlík M et al. Doporučení pro podávání biologické terapie u idiopatických střevních záně tů. Čes a Slov Gastroent a Hepatol 2008; 62(5): 285-291.
3. Lichtenstein G, Cohen R, Feagan B et al. Safety of infliximab in Crohn's disease: data from the 5000- patient TREAT Registry. Gastroenterology 2004; 126(Suppl 4): A54.
4. Mahadevan U, Terdiman J, Church J et al. Infliximab levels in infants born to women with inflammatory bowel disease. Gastroenterology 2007; 132 (Suppl 2): A144.
5. Cheent K, Nolan J, Shariq S et al. Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. J Crohns Colitis 2010; 4(5): 603-605.